 | Up a level |
Journal Article
Osterholt, Thomas 
ORCID: 0000-0001-5047-0252, Todorova, Polina Georgieva ORCID: 0000-0002-4728-224X, Kühne, Lucas ORCID: 0000-0002-5990-0279, Ehren, Rasmus ORCID: 0000-0002-3245-7481, Weber, Lutz T. ORCID: 0000-0003-4116-598X, Grundmann, Franziska ORCID: 0000-0002-5766-7477, Benzing, Thomas ORCID: 0000-0003-0512-1066, Brinkkötter, Paul T. ORCID: 0000-0002-4287-2080 and Völker, Linus A. ORCID: 0000-0002-4461-6128
(2023).
Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS.
Scientific Reports, 13 (1).
p. 6980.
Springer Nature.
ISSN 2045-2322
Kühne, Lucas ORCID: 0000-0002-5990-0279, Völker, Linus A. ORCID: 0000-0002-4461-6128, Hagmann, Henning, Hägele, Holger, Osterholt, Thomas ORCID: 0000-0001-5047-0252, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Thomas, Andreas, Breuer, Johanna, Grüttner, Berthold, Gottschalk, Ingo, Kann, Martin, Benzing, Thomas ORCID: 0000-0003-0512-1066, Thevis, Mario, Müller, Annette M. and Brinkkötter, Paul T. ORCID: 0000-0002-4287-2080
(2022).
First use of the anti‐VWF nanobody caplacizumab to treat iTTP in pregnancy.
British Journal of Haematology, 196 (3).
e30-e33.
Wiley-Blackwell.
ISSN 0007-1048